UniProt ID | ZNF44_HUMAN | |
---|---|---|
UniProt AC | P15621 | |
Protein Name | Zinc finger protein 44 | |
Gene Name | ZNF44 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 663 | |
Subcellular Localization | Nucleus . | |
Protein Description | May be involved in transcriptional regulation.. | |
Protein Sequence | MALCYGTFWGYPKMLEAANLMEGLVDIGPWVTLPRGQPEVLEWGLPKDQDSVAFEDVAVNFTHEEWALLGPSQKNLYRDVMRETIRNLNCIGMKWENQNIDDQHQNLRRNPRCDVVERFGKSKDGSQCGETLSQIRNSIVNKNTPARVDACGSSVNGEVIMGHSSLNCYIRVDTGHKHRECHEYAEKSYTHKQCGKGLSYRHSFQTCERPHTGKKPYDCKECGKTFSSPGNLRRHMVVKGGDGPYKCELCGKAFFWPSLLRMHERTHTGEKPYECKQCSKAFPVYSSYLRHEKIHTGEKPYECKQCSKAFPDYSSYLRHERTHTGEKPYKCKQCGKAFSVSGSLRVHERIHTGEKPYTCKQCGKAFCHLGSFQRHMIMHSGDGPHKCKICGKGFDFPGSARIHEGTHTLEKPYECKQCGKLLSHRSSFRRHMMAHTGDGPHKCTVCGKAFDSPSVFQRHERTHTGEKPYECKQCGKAFRTSSSLRKHETTHTGEQPYKCKCGKAFSDLFSFQSHETTHSEEEPYECKECGKAFSSFKYFCRHERTHSEEKSYECQICGKAFSRFSYLKTHERTHTAEKPYECKQCRKAFFWPSFLLRHERTHTGERPYECKHCGKAFSRSSFCREHERTHTGEKPYECKECGKAFSSLSSFNRHKRTHWKDIL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
126 | Phosphorylation | FGKSKDGSQCGETLS HCCCCCHHHHHHHHH | 32.22 | - | |
142 | Ubiquitination | IRNSIVNKNTPARVD HHHHHHCCCCCCCCC | 51.83 | - | |
246 | Sumoylation | KGGDGPYKCELCGKA ECCCCCEECCCCCCE | 25.11 | - | |
246 | Sumoylation | KGGDGPYKCELCGKA ECCCCCEECCCCCCE | 25.11 | - | |
258 | Phosphorylation | GKAFFWPSLLRMHER CCEEHHHHHHHHHHH | 30.54 | 22617229 | |
266 | Phosphorylation | LLRMHERTHTGEKPY HHHHHHHCCCCCCCC | 22.32 | 29396449 | |
268 | Phosphorylation | RMHERTHTGEKPYEC HHHHHCCCCCCCCCC | 46.56 | 29496963 | |
271 | Ubiquitination | ERTHTGEKPYECKQC HHCCCCCCCCCCCCC | 55.00 | - | |
296 | Phosphorylation | LRHEKIHTGEKPYEC HCCCCCCCCCCCCCC | 50.97 | 29496963 | |
322 | Phosphorylation | SYLRHERTHTGEKPY HHHCCCCCCCCCCCE | 22.32 | 28348404 | |
324 | Phosphorylation | LRHERTHTGEKPYKC HCCCCCCCCCCCEEC | 46.56 | 26270265 | |
327 | Ubiquitination | ERTHTGEKPYKCKQC CCCCCCCCCEECCCC | 55.80 | - | |
329 | Phosphorylation | THTGEKPYKCKQCGK CCCCCCCEECCCCCC | 39.83 | 29438985 | |
352 | Phosphorylation | RVHERIHTGEKPYTC EEEEEEECCCCCEEH | 44.67 | 27732954 | |
360 | Acetylation | GEKPYTCKQCGKAFC CCCCEEHHHCCCEEE | 40.60 | 18602967 | |
416 | Sumoylation | LEKPYECKQCGKLLS CCCCCCCHHHHHHHH | 36.36 | - | |
416 | Sumoylation | LEKPYECKQCGKLLS CCCCCCCHHHHHHHH | 36.36 | - | |
426 | Phosphorylation | GKLLSHRSSFRRHMM HHHHHCHHHHHHHHH | 28.53 | 18767875 | |
427 | Phosphorylation | KLLSHRSSFRRHMMA HHHHCHHHHHHHHHH | 23.80 | 17081983 | |
452 | Phosphorylation | VCGKAFDSPSVFQRH ECCCCCCCCHHHHHC | 16.78 | 28555341 | |
462 | Phosphorylation | VFQRHERTHTGEKPY HHHHCCCCCCCCCCC | 22.32 | 29396449 | |
464 | Phosphorylation | QRHERTHTGEKPYEC HHCCCCCCCCCCCCH | 46.56 | 29496963 | |
467 | Ubiquitination | ERTHTGEKPYECKQC CCCCCCCCCCCHHHH | 55.00 | - | |
472 | Sumoylation | GEKPYECKQCGKAFR CCCCCCHHHHCCEEE | 36.36 | - | |
472 | Sumoylation | GEKPYECKQCGKAFR CCCCCCHHHHCCEEE | 36.36 | - | |
527 | Sumoylation | EEEPYECKECGKAFS CCCCEEHHHHHHHHH | 44.06 | - | |
527 | Sumoylation | EEEPYECKECGKAFS CCCCEEHHHHHHHHH | 44.06 | - | |
534 | Phosphorylation | KECGKAFSSFKYFCR HHHHHHHHHHHHHHH | 39.46 | 29449344 | |
535 | Phosphorylation | ECGKAFSSFKYFCRH HHHHHHHHHHHHHHC | 21.21 | 29449344 | |
538 | Phosphorylation | KAFSSFKYFCRHERT HHHHHHHHHHHCCCC | 13.10 | 29449344 | |
565 | Phosphorylation | GKAFSRFSYLKTHER CHHHHHHCCCCCCCC | 28.57 | 24719451 | |
593 | Phosphorylation | RKAFFWPSFLLRHER HHHHHCHHHHHHCCC | 21.08 | 24719451 | |
629 | Phosphorylation | FCREHERTHTGEKPY HHHHCCCCCCCCCCE | 22.32 | 29396449 | |
631 | Phosphorylation | REHERTHTGEKPYEC HHCCCCCCCCCCEEH | 46.56 | 29496963 | |
634 | Ubiquitination | ERTHTGEKPYECKEC CCCCCCCCCEEHHHH | 55.00 | - | |
639 | Sumoylation | GEKPYECKECGKAFS CCCCEEHHHHHHHHH | 44.06 | - | |
639 | Ubiquitination | GEKPYECKECGKAFS CCCCEEHHHHHHHHH | 44.06 | - | |
639 | Sumoylation | GEKPYECKECGKAFS CCCCEEHHHHHHHHH | 44.06 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZNF44_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZNF44_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZNF44_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RDH13_HUMAN | RDH13 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND MASSSPECTROMETRY. |